Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02357368 · ClinicalTrials.gov registry record · Phase 4
Impact of Hormonal Contraception on HIV Acquisition and Transmission Risk
A Phase 4 study of HIV and Contraception, sponsored by Lisa Haddad.
- Completed
- Registry status
- Phase 4
- Development phase
- 59
- Enrollment target
- 4
- Study locations
NCT02357368 is a Phase 4 study of HIV and Contraception that has completed, run by Lisa Haddad. The registered enrollment target is 59 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (87% lower). The trial reports 4 study locations across 1 state.
The verdict
NCT02357368, a Phase 4 study of HIV and Contraception, has completed, sponsored by Lisa Haddad.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 59 participants
- Enrollment target
- 4
- Study locations
Study Summary
This is a prospective cohort study focusing on HIV negative women. The investigators want to learn how the contraceptive methods of depot medroxyprogesterone acetate (DMPA), etonogestrel implant (Eng-Implant), levonorgestrel intrauterine device (Lng-IUD) and the ParaGard® T 380A Intrauterine Copper Contraceptive impact the vaginal immune environment.
Conditions Studied
Interventions
- DRUG Depot medroxyprogesterone acetate (DMPA)
- DEVICE Etonogestrel implant (Eng-Implant)
- DEVICE Levonorgestrel intrauterine device (Lng-IUD)
- DEVICE ParaGard® T 380A Intrauterine Copper Contraceptive
Study Locations (4)
Georgia
- Grady Health System - Atlanta
- The Ponce de Leon Center of the Grady Health System - Atlanta
- Emory Clinic - Atlanta
- Emory University Clinical Research Network - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2015-02 |
| Est. Completion | 2019-10-23 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02357368
The ClinicalTrials.gov registry entry for NCT02357368 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 303 other HIV trials with a reported enrollment target (87% lower). The listed sponsor is Lisa Haddad, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 4 interventions - of which Depot medroxyprogesterone acetate (DMPA) is the first listed.
NCT02357368 reports 4 study locations spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT02357368 about?
NCT02357368 is a clinical study titled "Impact of Hormonal Contraception on HIV Acquisition and Transmission Risk". This is a prospective cohort study focusing on HIV negative women. The investigators want to learn how the contraceptive methods of depot medroxyprogesterone acetate (DMPA), etonogestrel implant (Eng-Implant), levonorgestrel intrauterine device (Lng-IUD) and the ParaGard® T 380A Intrauterine Copper ...
What is the current status of trial NCT02357368?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 59 participants. The study started on 2015-02. Estimated completion is 2019-10-23.
What conditions does trial NCT02357368 study?
This clinical trial studies the following conditions: HIV, Contraception.
What interventions are being tested in trial NCT02357368?
The interventions under investigation include: Depot medroxyprogesterone acetate (DMPA) (DRUG), Etonogestrel implant (Eng-Implant) (DEVICE), Levonorgestrel intrauterine device (Lng-IUD) (DEVICE), ParaGard® T 380A Intrauterine Copper Contraceptive (DEVICE).
Who is sponsoring clinical trial NCT02357368?
This trial is sponsored by Lisa Haddad, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02357368 being conducted?
This trial has 4 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV- Individuals With a History of Injection Drug Use
RECRUITING · Phase 4
-
Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women
RECRUITING · Phase 4
-
Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs
RECRUITING · Phase 4
-
Implementation and Deliver of Lenacapavir for PrEP in a Community Pharmacy Setting
RECRUITING · Phase 4
-
Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP
RECRUITING · Phase 4
-
Immediate Initiation of Antiretroviral Therapy During "Hyperacute" HIV Infection
ACTIVE NOT RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.